# Pusan National University Yangsan Hospital

Organization · id `cardio:org-pusan-national-university-yangsan-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 04kgg1090](<https://ror.org/04kgg1090>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 04kgg1090 by an exact name.

## The registry's words

- Sponsor name: Pusan National University Yangsan Hospital
- Sponsor class: OTHER
- ROR name: Pusan National University Yangsan Hospital

## Connected pages

- Sponsors: The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension (`cardio:ct-nct01135212`)
- Sponsors: A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension (`cardio:ct-nct01518998`)
- Sponsors: Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome (`cardio:ct-nct01660373`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)
- Sponsors: Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction (`cardio:ct-nct02224534`)
- Sponsors: Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling (`cardio:ct-nct05257824`)
- Sponsors: The Study for Evaluate of Satety and Dfficacy of Hemostatic Device (`cardio:ct-nct06590571`)

## Provenance

Content hash: 9db852b51d1d26357602ead8829ce9d9ba2abdb02829a130b8062d24fabe204f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
